Overcoming common pitfalls in lentiviral cell and gene therapies
BioPharma Dive,
Sponsored content Innovative cell and gene therapies could hold the keys to treating and potentially curing a wide range of…
Sponsored content Innovative cell and gene therapies could hold the keys to treating and potentially curing a wide range of…
The clinical trials necessary to bring a new molecular entity (NME) to market are costly—around $48 million per drug, according…
Sponsored content Cell and gene therapies are taking the world by storm. With CRISPR gene-editing technology, the genome is no…
Chimeric antigen receptor (CAR) T cells culminate from multiple significant advances in science, from tumor sequencing to…